Michael Forbes, CEO of Adastra, mentioned in his First press release: “Harm reduction is really a critically significant and mainstream subject, and we've been remaining within the forefront of drug rules over the board.”“We will Assess how the commercialization of this material suits in with our small business design at Adastra in order to p